Schiltz P M, Ohta T, Glass D, Mohan S, Baylink D J
Department of Orthopedic Surgery, Loma Linda University, CA 92350.
Endocr Res. 1992;18(1):19-30. doi: 10.1080/07435809209035925.
Daily subcutaneous injections of rat derived growth hormone to immature, hypophysectomized rats stimulated significant increases in body weight gain, serum osteocalcin, skeletal alkaline phosphatase and incorporation of radioactive thymidine and proline into the compact bone of femurs and tibiae. Equimolar doses of insulin-like growth factor-II did not produce similar biological effects. The data support the contention that growth hormone at equimolar concentration is a stronger osteogenic agent than is insulin-like growth factor-II in vivo.
对未成熟的垂体切除大鼠每日皮下注射大鼠源生长激素,可显著增加体重增加、血清骨钙素、骨特异性碱性磷酸酶,以及放射性胸苷和脯氨酸掺入股骨和胫骨密质骨的量。等摩尔剂量的胰岛素样生长因子-II未产生类似的生物学效应。这些数据支持了这样一种观点,即在体内等摩尔浓度的生长激素比胰岛素样生长因子-II是更强的成骨剂。